跳至主要内容
临床试验/JPRN-UMIN000046753
JPRN-UMIN000046753
已完成
未知

Verification of effects on brain activity, by taking a single dose of test food - Verification of effects on brain activity, by taking a single dose of test food

CPCC Company Limited0 个研究点目标入组 24 人2023年1月31日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Healthy male/female adults
发起方
CPCC Company Limited
入组人数
24
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年1月31日
结束日期
2022年3月8日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
CPCC Company Limited

入排标准

入选标准

  • 未提供

排除标准

  • (1\) Subjects being under some kind of continuous medical treatment, including the test period. (2\) Subjects who have periodically used health\-specific / functional / health foods including supplements, which might affect the autonomic nervous system, metabolism and sleep. (3\) Subjects with incompatible chest (e.g., thick bodyhair, pacemaker\-fitting) for heartbeat measurements. (4\) Subjects with excessive alcohol intake (not less than 60 g/day/week). (5\) Subjects with extremely irregular eating habits, and subjects having an irregular life rhythm with irregular shift work or midnight one. (6\) At the moment of informed consent, subjects who are under the other clinical tests with some kind of medicine/food, or participated in those within four weeks after the current trial, or are planning to join those after the consent. (7\) Subjects who are under a large stress condition with some kind of life event, such as house\-moving, transfer, bereavement, etc., within three months before the agreement for this trial and during the test period. (8\) Subjects with any difficulty in giving up drinking since the day before the scheduled date of this trial. (9\) Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. (10\) Subjects getting excessive exercise every day. (11\) Subjects with a serious symptom of premenstrual syndrome. (12\) Subjects who have been determined as poor blood circulation, according to the doctor's oral questions at the moment of informed consent. (13\) Subjects planning to vaccinate within three days before this study. (14\) Pregnant, possibly pregnant, and lactating women. (15\) Subjects having some kind of drug and/or food allergy. (16\) Subjects who break out in a rash from putting electrodes on the head and chest. (17\) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

结局指标

主要结局

未指定

相似试验